Format

Send to

Choose Destination
Clin Nucl Med. 2014 Jan;39(1):54-6. doi: 10.1097/RLU.0b013e318279ffc7.

Cardiac FDG-PET to assess sarcoidosis in a cardiac allograft.

Author information

1
From the Section of Cardiovascular Medicine, Yale University, New Haven, CT.

Abstract

A 58-year-old man with end-stage heart failure caused by cardiac sarcoidosis underwent an orthotopic heart transplant. His immediate posttransplant course was uncomplicated, but several months later, an endomyocardial biopsy revealed likely recurrent sarcoidosis. A cardiac F-FDG PET study subsequently showed focal anteroseptal uptake that suggested the presence of inflammation. Despite steroid therapy, a study repeated 3 months later showed persistent anteroseptal FDG uptake and new hypokinesis in that region. After escalating his steroid therapy, a final FDG-PET study ultimately demonstrated resolution of the uptake and normalization of anteroseptal wall motion.

PMID:
23603601
DOI:
10.1097/RLU.0b013e318279ffc7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center